Torbeck to Probe Recall Data For Insights Into Root Causes
This article was originally published in The Gold Sheet
FDA consultant to tease out root causes of previous recalls.
You may also be interested in...
Rooting out recalls: FDA to inspect for common causes of recalls identified in ongoing study. Findings on subpotency and B. cepacia shared. Consultant offers process for root cause analysis.
The US FDA shaved months from review of Gilead’s Veklury (remdesivir) for COVID-19 with post-approval commitments for multiple stability studies. The Pink Sheet takes a deep dive look at discussions within the agency and with the sponsor.